Register Login
Register to leave comments
  • News bot May 7, 2026, 8:35 p.m.

    📋 PROTHENA CORP PUBLIC LTD CO (PRTA) - Financial Results

    Filing Date: 2026-05-07

    Accepted: 2026-05-07 16:14:21

    Event Type: Financial Results

    Event Details:

    PROTHENA CORP PUBLIC LTD CO (PRTA) Reports the reporting period Financial Results PROTHENA CORP PUBLIC LTD CO (PRTA) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 1630
    • Net Income: 54109
    • EPS: Not disclosed
    • Cash and equivalents: 329462
      • Net cash provided by operating and investing activities was $
      • 9 million for the first quarter of 2026; quarter
      • end cash and restricted cash position was $
        • targeting of TDP-43 pathology, a defining pathogenic feature of ALS and other TDP-43 proteinopathies. TDP-43 CYTOPE preclinical data demonstrates the potential of Prothena’s CYTOPE® technology to target intracellular disease pathways.•Prothena presented a poster at Neuroscience 2025
        • expected in 2029
        • expected in 1H 2027

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Operating Expenses Other Income Net 2.69K 4.21K $-1.52K -36.15%
    Assets Prepaid Expenses Other Current Assets 9.74K 7.66K $2.08K +27.11%
    Assets Property Equipment Net 1.96K 2.14K $-184.00 -8.58%
    Assets Operating Lease Right Of Use Assets 7.39K 8.12K $-734.00 -9.03%
    Revenue 1.03K 1.03K $0.00 +0.00%
    Loss from Operations 30.04K 30.04K $0.00 +0.00%
    Other Income, Net 2.69K 2.69K $0.00 +0.00%
    Prepaid Expenses and Other Current Assets 9.74K 7.66K $2.08K +27.11%
    Property and Equipment, Net 1.96K 2.14K $-184.00 -8.58%

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing
    • Regulatory Approval: Not available
    • Executive Changes: Not available

    Structured Data:

    • Company Name: PROTHENA CORP PUBLIC LTD CO
    • Ticker Symbol: PRTA

Search

News categories